Biotechnology Instruments Market is projected to grow at a 16.4% CAGR during 2022-2032. Life science consumables segment to generate highest revenue.
ROCKVILLE, MARYLAND, UNITED STATES, May 27, 2022 /EINPresswire.com/ — As per a recent report published by Fact.MR, the global sales of Biotechnology Instruments is poised to grow at a CAGR of 14.4% from 2022 to 2032. During the said forecast period, the industry is likely to reach a valuation of nearly US$ 53.4 Billion in 2022, expected to close at a valuation of US$ 244 Billion. The widespread use of point-of-care diagnostic equipment is a key driver for the industry. R&D breakthroughs have continuously improved the capabilities of point-of-care (POC) testing systems.
Click Here To get a Sample Report (Including Full TOC, 54- Table & 114- Figures):-
From 2015 to 2021, the market for Biotechnology Instruments grew at a CAGR of 14.9%, closing at a value of US$ 46.4 Billion. As of 2022, the industry is likely to reach US$ 53.4 Billion. Life Science Consumables are expected to be the highest revenue-generating component, while Hospitals and Healthcare facilities are considered to be the highest revenue-generating end-user with a CAGR of 15.2% and 14.7% respectively during 2022 – 2032.
Several governments are concentrating on manufacturing advanced health infrastructure and also on developing new drugs for chronic diseases. Hence, they are making hefty investments in the R&D sector in the healthcare facilities and providing certain grants for the pharmaceutical companies to come up with improved results.
Key Takeaways from the Market Study
• Global biotechnology instruments market to flourish 4.5x from 2022-2032
• Biotechnology Life science consumables to be a top-selling category, capturing more than 50% revenue and flourishing at a 15.2% CAGR
• By end-use, biotechnology instruments for hospitals & healthcare facilities to expand at a CAGR of 14.7%
• North America to emerge as the fastest-growing Biotechnology Instruments market, documenting a 15.6% CAGR
• APAC to be the 2nd most opportunistic market, expected to be valued at US$ 40 Billion in 2032
Get Customisation of this Report at
“Frequent occurrence of chronic diseases such as cancer and diabetes have spurred development of new drugs. To reduce the cost of producing the new drug, prominent manufacturers are adopting innovative techniques and biotechnology instruments across the globe,” comments a Fact.MR analyst.
Key Segments Covered in the Biotechnology Instruments Industry Survey
• Biotechnology Instruments Market by Component :
o Biotechnology Lab Automation Instruments
Spatial Cell Analysis
Other Lab Automation Instruments
o Biotechnology Medical Lasers
o Biotechnology Life Science Consumables
• Biotechnology Instruments Market by End Use :
o Biotechnology Instruments for Government & Academic Institutes
o Biotechnology Instruments for Pharmaceutical & Biotechnology Companies
o Biotechnology Instruments for Hospitals & Healthcare Facilities
o Biotechnology Instruments for Other End-Uses
• Biotechnology Instruments Market by Region :
o North America Biotechnology Instruments Market
o Latin America Biotechnology Instruments Market
o Europe Biotechnology Instruments Market
o Asia Pacific Biotechnology Instruments Market
o The Middle East & Africa Biotechnology Instruments Market
Full Access of this Report Is Available At
The global market for biotechnology instruments is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.
• In February 2021, Waters Corporation launched a next-generation liquid chromatography system-Waters ACQUITY PREMIER Solution. It features the company’s breakthrough MaxPeak High-performance Surface technology.
• In July 2021, Lumenis introduced MOSES 2.0 Next-Generation Holmium Laser Technology. This launch was intended to increase the efficacy of urinary stones and enlarged prostate operation. This is feasible because of laser energy transfer improvement. Furthermore, increased investment initiatives aid many companies in expanding their market footprints.
More Valuable Insights
Fact.MR, in its new offering, presents an unbiased analysis of the global Biotechnology Instruments market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-to 2032.
The study reveals essential insights based on the basis of component (lab automation instruments, medical lasers and life science consumables) and end use (government & academic institutes, pharmaceutical & biotechnology companies, hospitals & healthcare facilities, other end-uses, healthcare biotechnology instruments and others) across five major regions (North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa).
Explore Fact.MR’s Coverage on the Healthcare Domain
Active Implantable Device Market ( https://www.factmr.com/report/1090/active-implantable-device-market ): Increasing prevalence of cardiovascular and neurological diseases is propelling the demand for electrical stimulation, timely delivery of medication, and hearing and dental prosthesis. This is projected to spur the sales of active implantable device.
ENT Medical Devices Market ( https://www.factmr.com/report/ent-medical-devices-market ): Growing incidence of ENT-related diseases among the geriatric population is augmenting the demand for rigid & flexible endoscopes, hearing aids & implant devices. This is anticipated to increase the adoption of ENT medical devices across the globe.
Hearing Amplifiers Market ( https://www.factmr.com/report/hearing-amplifiers-market ): Demand for hearing amplifiers is expected to rise owing to the rising prevalence of hearing impairment disorders. Furthermore, availability of cost effective hearing aids such as hearing amplifiers is projected to fuel the sales in the coming years.
Supriya Bhor Eminent Research & Advisory Services
EMINENT RESEARCH & ADVISORY SERVICES
email us here